News

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...
Some individuals living with obesity and overweight may find it difficult to embark on a weight loss journey alone. It’s not ...
Amycretin, a new weight-loss treatment from Novo Nordisk, combines two hunger hormones, helping participants lose nearly ...
For patients with IIH, sustainable weight loss offers the most effective and lasting relief from symptoms—and can help ...
Lifestyle therapy may not be enough to improve outcomes for patients with HF and obesity, but careful risk evaluation and ...
GLP-1 drugs like Ozempic help with weight loss, but how do they stack up against bariatric surgery? A new study breaks it ...
Glucagon-like peptide-1 (GLP-1) injections such as Wegovy (semaglutide) and Zepbound (tirzepatide) are the most effective weight-loss medications available today. Oral GLP-1 pills, such as ...
At the diabetes conference, Eli Lilly presented results of a phase 1 trial of its experimental drug, eloralintide. Unlike GLP ...
Pennsylvania Governor Josh Shapiro's office has said it is looking to change eligibility for weight loss drugs as part of its ...
Losing weight without trying might sound like a welcome surprise, but in some cases, it can be a sign of something more ...
Renowned endocrinologist and diabetologist Dr Ambrish Mithal told IndiaToday.in talked about muscle loss after consuming ...
Study comparing bariatric surgery to GLP-1 medications shows 24% total weight loss from surgery versus 4.7% from injectables, ...